Hanna M. Hieromnimon

Statistics

Publications

Citations

301

H-Index

Active since

2020

Affiliations

University of Chicago(Current)

University of Illinois Chicago

Cornell University

Hanna M. Hieromnimon is an author at University of Chicago specializing in pten inactivation, immune checkpoint inhibitors, and androgen deprivation therapy.

ORCID

Publications per year

2020–2024

Publications

Reversal of Lactate and PD-1–mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer

Kiranj Chaudagar, Hanna M. Hieromnimon, Rimpi Khurana et al. · Clinical Cancer Research · 2023 · 124 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Deep learning generates synthetic cancer histology for explainability and education

James M. Dolezal, Rachelle Wolk, Hanna M. Hieromnimon et al. · npj Precision Oncology · 2023 · 72 citations · Full text

Computing, Computer Science, Pathology +17

Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis

Kiranj Chaudagar, Hanna M. Hieromnimon, Anne Kelley et al. · Clinical Cancer Research · 2023 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17

Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent features

Frederick M. Howard, Hanna M. Hieromnimon, Siddhi Ramesh et al. · Science Advances · 2024 · 25 citations · Full text

Computing, Oncology, Pathology +16

Cabozantinib Unlocks Efficient <i>In Vivo</i> Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate Tumors

Kiranj Chaudagar, Natalie Landon‐Brace, Aniruddh Solanki et al. · Molecular Cancer Therapeutics · 2020 · 16 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

1–5 of 6